Медивитан

Quick links

Choose a section

Quick links to important sections

Advertisements

Медивитан

Selected form

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Медивитан

Quick Facts

Property Description
Active ingredients Cyanocobalamin (B12), Folic Acid (B9), Pyridoxine Hydrochloride (B6)
Form Solution for injection
Pharmacological class Vitamin B-complex, Metabolic agent
Common use Replenishment of essential micronutrients
Origin Synthetic

Медивитан: Definition and Pharmacological Classification

Медивитан is a pharmaceutical combination preparation formulated with high concentrations of three essential B vitamins, categorized broadly as a Vitamin B-complex and Metabolic agent. This specific medication is supplied exclusively as an aqueous solution for injection, intended for parenteral administration, signifying its classification as a prescription drug (Rx status). The choice of an injectable form is clinically recognized for ensuring the highest bioavailability of its components, bypassing the variable absorption experienced with many oral formulations.

Active Ingredients and Primary Composition

The core composition relies on the combination of Cyanocobalamin (Vitamin B12), Folic Acid (Vitamin B9), and Pyridoxine Hydrochloride (Vitamin B6) as its active components. This three-vitamin synergy relies on the specific interaction of these micronutrients acting in concert. The active ingredients are dissolved in a sterile, aqueous solution base suitable for intramuscular use. This targeted formulation provides the essential B vitamins in a precise ratio to support co-dependent metabolic pathways.

The General Purpose of This B-Vitamin Complex

The overall purpose of the B-vitamin complex in Медивитан is to restore or maintain cellular function by supplying indispensable coenzymes required for critical biochemical reactions. The specific synergy supports key functions, including nervous system maintenance and red blood cell formation (haematopoiesis). This mechanism is central to processes such as regulating homocysteine metabolism. This targeted action is fundamental to sustaining overall metabolic and neurological health.

Regulatory References

  1. MedlinePlus, NIH
Advertisements

What side effects are possible with Медивитан?

Possible Side Effects and Safety Information

The safety profile for this injectable B-vitamin combination is documented by regulatory authorities, classifying adverse reactions primarily by frequency and the body system affected. The documented effects pertain to the known characteristics of high-dose parenteral Cyanocobalamin (B12), Folic Acid (B9), and Pyridoxine (B6).

Adverse Reaction Classification

Frequency Classification Examples of Documented Reactions
Common Headache, mild diarrhea, dizziness, itching, or temporary hot flashes.
Rare Serious hypersensitivity reactions, cardiovascular effects.

System-Organ Classes and Serious Reactions

The most frequent effects involve the Gastrointestinal System and Skin. Reactions involving the Immune System are rare but critically important; documented reports include the possibility of anaphylactic shock or severe allergic reaction, which is a known, though very rare, risk with parenteral B12 administration. Serious cardiovascular reactions, such as pulmonary edema or congestive heart failure, may occur early in the treatment of severe underlying anemia.

Safety Patterns and Restrictions

Safety notes explicitly define risks related to exposure duration. The development of peripheral neuropathy is associated with the use of high doses and long-term exposure to Pyridoxine (B6), as specified in regulatory advisories. The medication is restricted for use in patients with known hypersensitivity to any component, including Cobalt (a part of the B12 molecule), or in individuals with Leber's Optic Atrophy, where B12 administration carries the risk of severe vision impairment. Furthermore, the administration of B vitamins may mask the true diagnosis of pernicious anemia.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Медивитан contains a combination of water-soluble vitamins (B6, B12, Folic Acid) and L-carnitine. While water-soluble components are generally excreted efficiently by the body, very high or prolonged intake of certain ingredients can lead to adverse effects.

Key Overdose Concerns (General)

The most significant concern associated with prolonged excessive intake is linked to Vitamin B6 (Pyridoxine). High doses over time, typically well above the established Upper Limit (UL) for daily intake, may cause sensory neuropathy. This condition involves nerve damage and can manifest as:

  • Peripheral Neuropathy: Numbness, tingling, or 'pins and needles' sensations, often starting in the hands and feet.
  • Ataxia: Difficulty with walking, balance, and coordination.
  • Muscle Weakness and loss of reflexes.

Overdose of L-carnitine is generally associated with gastrointestinal symptoms, including nausea, vomiting, diarrhea, and a distinctive 'fishy' body odor.

Required Emergency Actions

If you suspect an overdose of this product, or if you experience any signs of severe nervous system issues (such as new or worsening numbness, tingling, or difficulty walking), you must stop taking the product immediately and seek urgent medical attention. These symptoms should not be ignored, as continued intake could lead to the progression of nerve damage. Always contact emergency services or a poison control center for professional medical guidance.

Advertisements

Therapeutic Uses of Медивитан

What Медiвитан Treats: Main Uses and Benefits

The core therapeutic function of the B-vitamins in this medication is used for managing symptoms related to systemic imbalance that often involve nerve health and energy levels. As a recognized component of symptomatic management for nutritional imbalances, this medication is commonly used when short-term symptomatic assistance is needed and is considered relevant for easing deficiency-related manifestations.

Медiвитан is generally relevant for managing symptoms related to physical discomfort like tingling, numbness, burning sensations, and generalized physical weakness or exhaustion. This supportive relief contributes to improved comfort during periods of heightened symptoms and provides supportive relief when symptoms interfere with routine activities.

Therapeutic Scope

Commonly, this medication is applied in contexts where additional symptomatic support is needed for deficiency-related peripheral nerve distress, chronic fatigue, and during phases of recovery or high physiological tension. By acting as a supportive therapy, it helps address symptom clusters that may become intense or disruptive to daily functioning. Because Vitamin B12 is involved in maintaining nerve health, its use may be part of symptomatic management.

“This approach is relevant when symptoms become temporarily overwhelming.”

Quick Fact: Relief for Nerve Discomfort
Медiвитан is used for managing symptoms of increased neurological activity that interfere with daily comfort.

Regulatory References

  1. NIH MedlinePlus overview of Cyanocobalamin (Vitamin B12)
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Медивитан?

This section summarizes official regulatory information defining patient eligibility for Медивитан (a B-vitamin combination).

Contraindicated Populations (Must Not Use)

Category Restriction
Hypersensitivity Known allergy to any active substance or excipient.
Malignancy Patients with active or suspected malignant disease.
Anemia Type Treatment of isolated folic acid deficiency in megaloblastic anemia (Vitamin B12 deficiency must be ruled out).

Restricted or Special Consideration Populations

Category Eligibility Status
Pediatric Use Not recommended for children and adolescents (under 18 years) due to insufficient clinical data.
Renal Impairment Use requires special consideration in patients with severe renal insufficiency.
Pregnancy/Lactation Use is permitted only to correct a documented deficiency where the benefit is deemed to outweigh the potential risks.

Overall Eligibility: Use is generally restricted to adults with a confirmed diagnosis of the relevant vitamin deficiencies where parenteral administration is indicated. Use is formally contraindicated in cases of known allergy, malignant disease, and specific types of anemia. Decisions regarding use must strictly adhere to the official eligibility criteria defined in regulatory labeling.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Медивитан (containing Cyanocobalamin (B12), Folic Acid (B9), and Pyridoxine (B6)) details specific pharmacological constraints documented in official regulatory labeling. These interactions primarily involve alterations in drug efficacy, plasma exposure, or absorption.


Official Interaction Statements

  • Pyridoxine (B6) may reduce the therapeutic efficacy of Levodopa (L-Dopa), unless Levodopa is co-administered with a Dopa-decarboxylase inhibitor.
  • Folic Acid (B9) can interact with agents that inhibit folate metabolism (Folic Acid Antagonists, such as Methotrexate), potentially weakening their action. High-dose Folic Acid may also reduce the serum levels of certain anticonvulsants (e.g., Phenytoin).
  • The co-administration of Folic Acid with Fluorouracil may enhance the toxic effect of the chemotherapy agent.
  • Specific medicinal products categorized as Pyridoxine Antagonists (e.g., Isoniazid) are officially noted to increase the physiological requirement for Vitamin B6.
  • Cholestyramine and certain aluminum- and magnesium-containing antacids may interfere with Folic Acid absorption, requiring mandated separation of administration times as detailed in the prescribing information.
  • Chronic heavy alcohol intake is documented to potentially reduce the absorption of Cyanocobalamin (B12). For patients with impaired kidney function, prolonged parenteral administration carries a documented risk of aluminum accumulation from components in some injectable vitamin formulations.
Advertisements

Mechanism of Action

Медивитан functions as a metabolic enablement strategy, directly supplying the body with the precursors for essential coenzymes ( B6, B12, Folic Acid). Its mechanism involves supporting foundational biochemical processes critical for cellular and nervous system health.

Coenzyme Provision and Energy Metabolism

The active vitamin forms bind to and activate a vast array of metabolic enzymes, functioning as essential cofactors for transamination and decarboxylation. This action sustains the cellular capacity to process amino acids and fats, supporting cellular energy metabolism and the maintenance of metabolic stability in tissues.

C1 Cycle and Homocysteine Regulation

The core synergistic mechanism involves the vitamins regulating the One-Carbon ( C1) Metabolic Cycle. B12 and Folic Acid work together to convert the amino acid Homocysteine back into Methionine, while B6 provides an alternate catabolic pathway. The active vitamin forms interact with and activate the enzymes of the Homocysteine cycle. This cascade is crucial for DNA synthesis, blood cell formation, and reducing the accumulation of metabolic intermediates that may affect the cardiovascular and nervous systems .

Neurotrophic Cofactors and Myelin Integrity

The active components provide cofactors necessary for the structure and function of the entire nervous system. B12 is fundamentally required for the synthesis and repair of the myelin sheath, which insulates nerve fibers, while B6 is a cofactor for synthesizing critical neurotransmitters like serotonin and GABA. This collective support contributes to sustaining nerve conduction velocity and maintaining neuronal signaling fidelity.

Advertisements

Dosage and Administration Information

The administration of Медивитан typically follows a two-phase protocol designed for delivery by a healthcare professional. The medication is supplied exclusively as an aqueous solution for injection, with the primary and most common route being Intramuscular (IM) injection into a suitable muscle.

The use pattern is typically divided into an intensive, short-term treatment followed by a long-term, supportive schedule. The Initial Phase involves administering the standard adult dose of approximately one ampoule (5 mL), delivered daily for a course duration often lasting 5 to 10 days. This initial phase establishes therapeutic support. Following this, the regimen transitions into a Maintenance Phase, where the administration frequency is reduced to an intermittent schedule, such as once or twice per week. Long-term use is typically organized into defined treatment cycles rather than continuous daily application.

Procedural instructions dictate that the dose is not self-administered. When the secondary route of Intravenous (IV) administration is utilized, the solution may require dilution with an appropriate fluid and must be injected slowly or delivered as an infusion over a set time period. Standard adult dosing applies to older adults, as standard clinical parameters for this combination do not generally specify universal, formulaic dose reductions for this group.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Медивитан

Evidence for use in Symptoms of Peripheral Nerve Distress

Research has examined B-vitamin combinations (including B6, B12, and Folic Acid) in studies assessing symptoms associated with nerve function. Study designs included short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. Researchers examined outcomes related to physical discomfort, such as patient-reported tingling and pain, as well as objective measures of nerve function. Populations primarily included adults diagnosed with Diabetic Peripheral Neuropathy (DPN) and cancer patients undergoing chemotherapy.

Some trials described patterns observed in the patient-reported outcomes for symptoms during the study period. However, the data showed variability when researchers monitored objective nerve function. Evidence structure varies across studies, and much foundational research was studied using oral vitamin supplements, meaning comparative evidence for the injectable administration is limited.


Evidence for Metabolic Biomarker Evaluation (Homocysteine)

Research has examined the effect of this B-vitamin combination on the blood biomarker Homocysteine (HCY). The highest level of evidence is derived from Meta-Analyses of Randomized Controlled Trials which was observed in populations of adults with Type 2 Diabetes Mellitus (T2DM) and individuals with severe kidney disease. Data show patterns related to a consistent shift in the HCY biomarker following B-vitamin administration.

However, research has explored whether this change in the blood marker is associated with major clinical outcomes, such as a lower incidence of cardiovascular complications or fracture risk. Research indicates data variability on this point, and the relationship between the measured change in the biomarker and long-term clinical events is not fully established.


What Is Still Uncertain About the Research for Медивитан

A summary of the evidence highlights several areas where certainty remains low. Evidence structure varies across studies, particularly for subjective outcomes. Findings were mixed regarding whether the reduction in the Homocysteine biomarker is associated with long-term health changes. Long-term effects are not fully established, as most trials focused on episodes where symptoms become more noticeable over short to intermediate time intervals.

Key Studies & References

  1. Cyanocobalamin (Vitamin B12): Drug Information. MedlinePlus, National Library of Medicine (NIH)
  2. Homocysteine. MedlinePlus, National Library of Medicine (NIH)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Медивитан (FAQ)

Q: Is Medivitan a vitamin or a medicine?

Medivitan is officially classified as a pharmaceutical combination preparation that contains a high dose of B-complex vitamins (B6, B12, and Folic Acid). According to regulatory documents, it is assigned an Rx-status (prescription drug) and belongs to the pharmacological group of Metabolic Agents due to its role in essential bodily processes.


Q: How quickly does Medivitan start to work?

Because Medivitan is administered via injection, its active ingredients are delivered to the body, which ensures high bioavailability. Official prescribing information indicates that the maximum concentration of some components in the blood is typically reached in about one hour following intramuscular injection.


Q: How long can I take Medivitan for?

The duration of use is typically determined by the prescribing healthcare professional and organized into specific treatment cycles and supportive phases. Official safety information notes that long-term exposure to high doses, particularly of Pyridoxine (B6), is associated with a documented risk of developing peripheral neuropathy.


Q: Is it true that Medivitan improves the function of the nervous system?

Official documents describe the active components as cofactors that support the structure and function of the entire nervous system. The product is noted for supporting the integrity of the myelin sheath (which insulates nerves) and the synthesis of important neurotransmitters.


Q: Is it true that Medivitan helps with fatigue and stress?

The primary official use of the product is to replenish a combined deficiency of B6, B12, and Folic Acid. In certain regulatory contexts, the product is indicated to provide metabolic support when increased fatigue and low energy are related to a diagnosed vitamin deficiency addressed by the preparation.


Q: Can Medivitan affect sleep or mood?

Official documentation on side effects does not commonly list sleep disturbance or mood changes. The product is noted for supporting overall nervous system function. Any unusual reactions should be discussed with a healthcare professional.


Q: Is it true that Medivitan is used to support the heart?

Official mechanisms of action describe the vitamins' role in regulating the blood marker Homocysteine (HCY), which is a molecule studied in the context of cardiovascular health. It is not an officially indicated drug for heart disease treatment.


Q: Does Medivitan affect blood pressure?

The official package insert does not specifically list changes in blood pressure as a common side effect. Rare, serious cardiovascular reactions have been documented in the safety profile.


Q: Why is Medivitan called a B-complex vitamin?

It is named a B-complex because the preparation contains a synergistic combination of three different essential vitamins that belong to the B group: Pyridoxine (B6), Cyanocobalamin (B12), and Folic Acid (B9).


Q: Can taking Medivitan cause a headache?

Official safety data indicates that headache is documented as a common side effect that may be observed during treatment with the injection.


Q: Does Medivitan change the color of urine, and is this normal?

While not explicitly listed in the formal side effect profile, an increased intensity of urine color (e.g., bright yellow) is a known and expected physiological outcome when taking high doses of B-vitamins. This occurs because the body excretes excess water-soluble vitamins through the kidneys.


Q: Does Medivitan have a cumulative effect in the body?

Yes, its components are known to be stored in the body, primarily in the liver. This ability to accumulate is why the product's use is structured into defined therapeutic cycles rather than continuous daily administration, as determined by the prescribing professional.


Q: Why do some people not feel an effect from Medivitan?

Official research overviews note that the data on outcomes is variable, and the clinical conclusions are not fully established for all parameters studied. A lack of perceived effect may be related to these research uncertainties or individual metabolic factors.


Q: What is the difference between Medivitan and other similar vitamin complexes?

The key distinction noted in official documents is its formulation as an aqueous solution for injection. This parenteral route is used to ensure the highest bioavailability of the components compared to oral complexes.


Q: Is it necessary to take a break from Medivitan?

The administration regimen is structured into an Initial Intensive Phase followed by a Maintenance Phase and is often organized into treatment cycles. This treatment structure, as prescribed by a doctor, inherently includes periods of non-daily use.


Q: What is the difference between Medivitan tablets and injections?

The official formulation of Medivitan is exclusively a sterile aqueous solution for injection. The injectable form is noted for achieving high bioavailability in the bloodstream.


Q: Why do doctors frequently prescribe Medivitan?

The frequent prescribing may be attributed to the fact that its injectable form is noted for providing high bioavailability of the active components, bypassing potential issues with absorption in the digestive tract.


Q: What official studies support the action of Medivitan?

Research, including Randomized Controlled Trials (RCTs) and Meta-analyses, has examined the B-vitamin complex for two main areas: assessing symptoms related to nerve function and evaluating its effect on the Homocysteine biomarker.


Q: Why does the package insert mention specific disease groups?

The official indications (uses) are often limited to specific disease groups (e.g., diabetic peripheral neuropathy, certain anemias) because these are the populations where the key clinical trials were conducted and on which the regulatory approvals are based.


Q: What is the expected benefit of taking Medivitan?

The purpose is to address a diagnosed deficiency by supplying B6, B12, and Folic Acid. This action is pharmacologically intended to support nervous system maintenance, red blood cell formation, and the regulation of Homocysteine metabolism.


Q: Can I have an allergy to Medivitan?

Known hypersensitivity (allergy) to any component of the product is listed as a contraindication in official labeling. The safety profile documents the rare, but serious, risk of anaphylactic shock (a severe allergic reaction).


Q: Can I drink alcohol while taking Medivitan?

Official product information notes that chronic heavy alcohol intake may reduce the absorption of Cyanocobalamin (B12), which is one of the active ingredients in the product.


Q: Is Medivitan considered a safe medicine?

Regulatory authorities document a full safety profile that includes contraindications, warnings, and potential side effects. The medication is approved for use only when strictly following these instructions and under the supervision and guidance of a healthcare professional.


Q: Can I buy Medivitan without a prescription?

Medivitan is classified as a prescription drug (Rx-status). This means the product is generally only available for purchase with a valid prescription from a licensed healthcare provider.


Q: How long should I wait to feel an improvement in my condition?

While the active components are immediately available, patient information suggests that a noticeable effect may be felt relatively soon, sometimes after the first injection. However, achieving the full therapeutic improvement typically requires completing the course of therapy as prescribed by a doctor.


Q: What does it mean if the package insert says it is a 'deficiency replenishment agent'?

This term means the product is used to restore the normal level of vitamins B6, B12, and Folic Acid in the body. The medication is specifically indicated when a confirmed deficiency of these vitamins exists and cannot be effectively corrected through diet alone.


Q: Are there special instructions for vegetarians/vegans taking Medivitan?

The active ingredients (B6, B12, Folic Acid) are synthetic in origin. Cyanocobalamin (B12), in particular, is a vitamin frequently recommended to correct deficiencies in individuals following vegetarian and vegan diets.


Q: Does Medivitan contain sugar or lactose?

According to the official composition, Medivitan is an aqueous solution for injection. The excipients listed are sodium chloride and water for injection. It does not contain sugar or lactose.


Q: Why does Medivitan have a different composition in some countries?

There are different brands using B-vitamin combinations globally. The specific composition and final formulation of a drug may vary slightly between countries due to differences in national regulatory requirements and how the product is licensed and marketed.


Q: Can Medivitan cause skin problems, such as a rash?

The official safety profile indicates that reactions affecting the skin, such as itching, are considered frequent side effects. More serious but rare allergic reactions (hypersensitivity) may also manifest as a rash.


Q: In what cases will taking Medivitan not have any effect?

The product is unlikely to have a therapeutic effect if the patient does not have a confirmed deficiency of B6, B12, or Folic Acid, or if their condition is caused by an illness for which the medication is not officially indicated.


Q: Is it true that the B vitamins in Medivitan are better absorbed?

Official information indicates that the injectable solution form was chosen to provide high bioavailability. This means the active components are designed to be completely and quickly available to the bloodstream, bypassing potential digestive issues.


Q: How is it determined who should take Medivitan and who should not?

Use is generally restricted to adults who have a confirmed diagnosis of a deficiency that requires parenteral administration. Its use is contraindicated in cases of known allergy, malignant disease, and specific types of anemia.

Advertisements

How should Медивитан be stored and disposed of?

Official Storage and Disposal Instructions

The storage and disposal of the Medivitan injectable solution are governed by specific regulatory requirements to ensure product stability and safety. The product must be protected from light and maintained within a strict temperature range.

Storage Requirement Official Regulatory Statement
Temperature Store at a temperature no higher than 25 C (77 F)
Protection Protect from light and do not freeze the solution.
Packaging Store in the original outer carton to protect the contents from light.
Child Safety Keep out of the sight and reach of children (standard regulatory mandate).

Disposal of unused or expired Medivitan must follow pharmaceutical waste protocols. Regulatory guidance explicitly states that the medicine must not be disposed of via wastewater or household waste. All unused product must be returned to a pharmacy or a designated local collection point for disposal in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Медивитан found in:

A-Z Index: